Vincenti, Flavio, et al. “A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis”. 2017. Kidney International Reports, vol. 2, no. 5, 2017, pp. 800–810.